Background Mitral valve repair and replacement (MVR) with preservation
of the tendinous chordae [MVR(p)], may have better results than MVR w
ith valve excision [MVR(e)]. It is not known whether the type of surge
ry affects in-hospital stay and cost. Methods and Results We reviewed
all patients who had mitral valve surgery for regurgitation over 5 yea
rs from January 1991. Patients were considered in three groups; MVR(e)
, MVR(p), and Repair. Cost was calculated using operating room, intens
ive care unit, and ward expenses, not hospital charges. There were a t
otal of 253 patients; 84 MVR(e), 42 MVR(p), and 127 Repair. Mean ages
and preoperative New York Heart Association (NYHA) classes were simila
r in the three groups. There were more male patients in the Repair (62
%) and MVR(p) (67%) groups than in the MVR(e) (44%) group (P<.05), and
more patients with degenerative etiology in the Repair group (P<.01).
A majority of MVR(e) were in atrial fibrillation (63%), while 59% of
Repair were in sinus rhythm (P<.01). Of 9 patients who died in the hos
pital; four had MVR(e), 3 had MVR(p), and 2 had Repair. In univariate
analyses, in-hospital stay increased with patient age >70 years (P<.01
), preoperative atrial fibrillation (P<.05), and NYHA class III or IV
(P<.01). The median and interquartile ranges for postoperative stay wa
s 10 (8 to 13) days for MVR(e), 8 (7 to 11) days for MVR(p), and 8 (7
to 10) days for Repair (P<.01 versus MVR(e); multivariate analysis adj
usting for age, rhythm, and NYHA class). Cost per patient was US $1446
9 for MVR(e), $13 151 for MVR(p), and $11606 for Repair. Conclusions R
epair and MVR(p) may predict shorter in-hospital stay and reduced cost
, although there are important differences in the group of patients wh
o have MVR(e).